Actively Recruiting
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
Led by Scripps Health · Updated on 2026-04-09
60
Participants Needed
1
Research Sites
395 weeks
Total Duration
On this page
Sponsors
S
Scripps Health
Lead Sponsor
S
Scripps Clinic
Collaborating Sponsor
AI-Summary
What this Trial Is About
This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.
CONDITIONS
Official Title
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients aged 18 or older at the time of study informed consent.
- Plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood.
- Recipients of non-myeloablative, myeloablative, or reduced intensity conditioning are eligible.
- Have access to a digital device capable of downloading the study app.
- Able to read study documents and complete informed consent within the study app.
You will not qualify if you...
- Failed prior allogeneic hematopoietic stem cell transplant within the past 6 months.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Scripps Health
San Diego, California, United States, 92037
Actively Recruiting
Research Team
J
Jake New, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here